Point-of-care testing, medical error, and patient safety: a 2007 assessment
Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment,...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Ehrmeyer, Sharon S. [verfasserIn] Laessig, Ronald H. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Walter de Gruyter ; 2007 |
|---|
| Schlagwörter: |
Clinical Laboratory Improvement Amendments (CLIA) regulation |
|---|
| Anmerkung: |
©2007 by Walter de Gruyter Berlin New York |
|---|---|
| Umfang: |
8 |
| Reproduktion: |
Walter de Gruyter Online Zeitschriften |
|---|---|
| Übergeordnetes Werk: |
Enthalten in: Clinical chemistry and laboratory medicine - Berlin [u.a.] : De Gruyter, 1998, 45(2007), 6 vom: 19. Juni, Seite 766-773 |
| Übergeordnetes Werk: |
volume:45 ; year:2007 ; number:6 ; day:19 ; month:06 ; pages:766-773 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1515/CCLM.2007.164 |
|---|
| Katalog-ID: |
NLEJ246720352 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ246720352 | ||
| 003 | DE-627 | ||
| 005 | 20230506100849.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220814s2007 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1515/CCLM.2007.164 |2 doi | |
| 028 | 5 | 2 | |a artikel_Grundlieferung.pp |
| 035 | |a (DE-627)NLEJ246720352 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a Ehrmeyer, Sharon S. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Point-of-care testing, medical error, and patient safety: a 2007 assessment |
| 264 | 1 | |b Walter de Gruyter |c 2007 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a ©2007 by Walter de Gruyter Berlin New York | ||
| 520 | |a Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73. | ||
| 533 | |f Walter de Gruyter Online Zeitschriften | ||
| 650 | 4 | |a Clinical Laboratory Improvement Amendments (CLIA) regulation | |
| 650 | 4 | |a clinical laboratory testing | |
| 650 | 4 | |a errors | |
| 650 | 4 | |a patient safety | |
| 650 | 4 | |a point-of-care testing | |
| 650 | 4 | |a quality | |
| 700 | 1 | |a Laessig, Ronald H. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d Berlin [u.a.] : De Gruyter, 1998 |g 45(2007), 6 vom: 19. Juni, Seite 766-773 |w (DE-627)NLEJ248235222 |w (DE-600)1492732-9 |x 1437-4331 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2007 |g number:6 |g day:19 |g month:06 |g pages:766-773 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1515/CCLM.2007.164 |z Deutschlandweit zugänglich |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DGR | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2007 |e 6 |b 19 |c 06 |h 766-773 |g 8 | ||
| author_variant |
s s e ss sse r h l rh rhl |
|---|---|
| matchkey_str |
article:14374331:2007----::onocrtsigeiaerrnptetae |
| hierarchy_sort_str |
2007 |
| publishDate |
2007 |
| allfields |
10.1515/CCLM.2007.164 doi artikel_Grundlieferung.pp (DE-627)NLEJ246720352 DE-627 ger DE-627 rakwb Ehrmeyer, Sharon S. verfasserin aut Point-of-care testing, medical error, and patient safety: a 2007 assessment Walter de Gruyter 2007 8 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier ©2007 by Walter de Gruyter Berlin New York Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73. Walter de Gruyter Online Zeitschriften Clinical Laboratory Improvement Amendments (CLIA) regulation clinical laboratory testing errors patient safety point-of-care testing quality Laessig, Ronald H. verfasserin aut Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 45(2007), 6 vom: 19. Juni, Seite 766-773 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:45 year:2007 number:6 day:19 month:06 pages:766-773 extent:8 https://doi.org/10.1515/CCLM.2007.164 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 45 2007 6 19 06 766-773 8 |
| spelling |
10.1515/CCLM.2007.164 doi artikel_Grundlieferung.pp (DE-627)NLEJ246720352 DE-627 ger DE-627 rakwb Ehrmeyer, Sharon S. verfasserin aut Point-of-care testing, medical error, and patient safety: a 2007 assessment Walter de Gruyter 2007 8 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier ©2007 by Walter de Gruyter Berlin New York Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73. Walter de Gruyter Online Zeitschriften Clinical Laboratory Improvement Amendments (CLIA) regulation clinical laboratory testing errors patient safety point-of-care testing quality Laessig, Ronald H. verfasserin aut Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 45(2007), 6 vom: 19. Juni, Seite 766-773 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:45 year:2007 number:6 day:19 month:06 pages:766-773 extent:8 https://doi.org/10.1515/CCLM.2007.164 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 45 2007 6 19 06 766-773 8 |
| allfields_unstemmed |
10.1515/CCLM.2007.164 doi artikel_Grundlieferung.pp (DE-627)NLEJ246720352 DE-627 ger DE-627 rakwb Ehrmeyer, Sharon S. verfasserin aut Point-of-care testing, medical error, and patient safety: a 2007 assessment Walter de Gruyter 2007 8 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier ©2007 by Walter de Gruyter Berlin New York Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73. Walter de Gruyter Online Zeitschriften Clinical Laboratory Improvement Amendments (CLIA) regulation clinical laboratory testing errors patient safety point-of-care testing quality Laessig, Ronald H. verfasserin aut Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 45(2007), 6 vom: 19. Juni, Seite 766-773 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:45 year:2007 number:6 day:19 month:06 pages:766-773 extent:8 https://doi.org/10.1515/CCLM.2007.164 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 45 2007 6 19 06 766-773 8 |
| allfieldsGer |
10.1515/CCLM.2007.164 doi artikel_Grundlieferung.pp (DE-627)NLEJ246720352 DE-627 ger DE-627 rakwb Ehrmeyer, Sharon S. verfasserin aut Point-of-care testing, medical error, and patient safety: a 2007 assessment Walter de Gruyter 2007 8 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier ©2007 by Walter de Gruyter Berlin New York Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73. Walter de Gruyter Online Zeitschriften Clinical Laboratory Improvement Amendments (CLIA) regulation clinical laboratory testing errors patient safety point-of-care testing quality Laessig, Ronald H. verfasserin aut Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 45(2007), 6 vom: 19. Juni, Seite 766-773 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:45 year:2007 number:6 day:19 month:06 pages:766-773 extent:8 https://doi.org/10.1515/CCLM.2007.164 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 45 2007 6 19 06 766-773 8 |
| allfieldsSound |
10.1515/CCLM.2007.164 doi artikel_Grundlieferung.pp (DE-627)NLEJ246720352 DE-627 ger DE-627 rakwb Ehrmeyer, Sharon S. verfasserin aut Point-of-care testing, medical error, and patient safety: a 2007 assessment Walter de Gruyter 2007 8 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier ©2007 by Walter de Gruyter Berlin New York Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73. Walter de Gruyter Online Zeitschriften Clinical Laboratory Improvement Amendments (CLIA) regulation clinical laboratory testing errors patient safety point-of-care testing quality Laessig, Ronald H. verfasserin aut Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 45(2007), 6 vom: 19. Juni, Seite 766-773 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:45 year:2007 number:6 day:19 month:06 pages:766-773 extent:8 https://doi.org/10.1515/CCLM.2007.164 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 45 2007 6 19 06 766-773 8 |
| source |
Enthalten in Clinical chemistry and laboratory medicine 45(2007), 6 vom: 19. Juni, Seite 766-773 volume:45 year:2007 number:6 day:19 month:06 pages:766-773 extent:8 |
| sourceStr |
Enthalten in Clinical chemistry and laboratory medicine 45(2007), 6 vom: 19. Juni, Seite 766-773 volume:45 year:2007 number:6 day:19 month:06 pages:766-773 extent:8 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Clinical Laboratory Improvement Amendments (CLIA) regulation clinical laboratory testing errors patient safety point-of-care testing quality |
| isfreeaccess_bool |
false |
| container_title |
Clinical chemistry and laboratory medicine |
| authorswithroles_txt_mv |
Ehrmeyer, Sharon S. @@aut@@ Laessig, Ronald H. @@aut@@ |
| publishDateDaySort_date |
2007-06-19T00:00:00Z |
| hierarchy_top_id |
NLEJ248235222 |
| id |
NLEJ246720352 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ246720352</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506100849.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220814s2007 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/CCLM.2007.164</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">artikel_Grundlieferung.pp</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ246720352</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ehrmeyer, Sharon S.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Point-of-care testing, medical error, and patient safety: a 2007 assessment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">Walter de Gruyter</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">©2007 by Walter de Gruyter Berlin New York</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Walter de Gruyter Online Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Laboratory Improvement Amendments (CLIA) regulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">clinical laboratory testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">errors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">patient safety</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">point-of-care testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">quality</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Laessig, Ronald H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Clinical chemistry and laboratory medicine</subfield><subfield code="d">Berlin [u.a.] : De Gruyter, 1998</subfield><subfield code="g">45(2007), 6 vom: 19. Juni, Seite 766-773</subfield><subfield code="w">(DE-627)NLEJ248235222</subfield><subfield code="w">(DE-600)1492732-9</subfield><subfield code="x">1437-4331</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:45</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:6</subfield><subfield code="g">day:19</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:766-773</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/CCLM.2007.164</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DGR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">45</subfield><subfield code="j">2007</subfield><subfield code="e">6</subfield><subfield code="b">19</subfield><subfield code="c">06</subfield><subfield code="h">766-773</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| series2 |
Walter de Gruyter Online Zeitschriften |
| author |
Ehrmeyer, Sharon S. |
| spellingShingle |
Ehrmeyer, Sharon S. misc Clinical Laboratory Improvement Amendments (CLIA) regulation misc clinical laboratory testing misc errors misc patient safety misc point-of-care testing misc quality Point-of-care testing, medical error, and patient safety: a 2007 assessment |
| authorStr |
Ehrmeyer, Sharon S. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ248235222 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
NL |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1437-4331 |
| topic_title |
Point-of-care testing, medical error, and patient safety: a 2007 assessment Clinical Laboratory Improvement Amendments (CLIA) regulation clinical laboratory testing errors patient safety point-of-care testing quality |
| publisher |
Walter de Gruyter |
| publisherStr |
Walter de Gruyter |
| topic |
misc Clinical Laboratory Improvement Amendments (CLIA) regulation misc clinical laboratory testing misc errors misc patient safety misc point-of-care testing misc quality |
| topic_unstemmed |
misc Clinical Laboratory Improvement Amendments (CLIA) regulation misc clinical laboratory testing misc errors misc patient safety misc point-of-care testing misc quality |
| topic_browse |
misc Clinical Laboratory Improvement Amendments (CLIA) regulation misc clinical laboratory testing misc errors misc patient safety misc point-of-care testing misc quality |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Clinical chemistry and laboratory medicine |
| hierarchy_parent_id |
NLEJ248235222 |
| hierarchy_top_title |
Clinical chemistry and laboratory medicine |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ248235222 (DE-600)1492732-9 |
| title |
Point-of-care testing, medical error, and patient safety: a 2007 assessment |
| ctrlnum |
(DE-627)NLEJ246720352 |
| title_full |
Point-of-care testing, medical error, and patient safety: a 2007 assessment |
| author_sort |
Ehrmeyer, Sharon S. |
| journal |
Clinical chemistry and laboratory medicine |
| journalStr |
Clinical chemistry and laboratory medicine |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2007 |
| contenttype_str_mv |
txt |
| container_start_page |
766 |
| author_browse |
Ehrmeyer, Sharon S. Laessig, Ronald H. |
| container_volume |
45 |
| physical |
8 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Ehrmeyer, Sharon S. |
| doi_str_mv |
10.1515/CCLM.2007.164 |
| author2-role |
verfasserin |
| title_sort |
point-of-care testing, medical error, and patient safety: a 2007 assessment |
| title_auth |
Point-of-care testing, medical error, and patient safety: a 2007 assessment |
| abstract |
Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73. ©2007 by Walter de Gruyter Berlin New York |
| abstractGer |
Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73. ©2007 by Walter de Gruyter Berlin New York |
| abstract_unstemmed |
Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73. ©2007 by Walter de Gruyter Berlin New York |
| collection_details |
GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE |
| container_issue |
6 |
| title_short |
Point-of-care testing, medical error, and patient safety: a 2007 assessment |
| url |
https://doi.org/10.1515/CCLM.2007.164 |
| remote_bool |
true |
| author2 |
Laessig, Ronald H. |
| author2Str |
Laessig, Ronald H. |
| ppnlink |
NLEJ248235222 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1515/CCLM.2007.164 |
| up_date |
2024-07-06T09:10:41.743Z |
| _version_ |
1803820247804805120 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ246720352</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506100849.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220814s2007 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/CCLM.2007.164</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">artikel_Grundlieferung.pp</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ246720352</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ehrmeyer, Sharon S.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Point-of-care testing, medical error, and patient safety: a 2007 assessment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">Walter de Gruyter</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">©2007 by Walter de Gruyter Berlin New York</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. “Errors” in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers – incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results – lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results – an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place. Clin Chem Lab Med 2007;45:766–73.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Walter de Gruyter Online Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Laboratory Improvement Amendments (CLIA) regulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">clinical laboratory testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">errors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">patient safety</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">point-of-care testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">quality</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Laessig, Ronald H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Clinical chemistry and laboratory medicine</subfield><subfield code="d">Berlin [u.a.] : De Gruyter, 1998</subfield><subfield code="g">45(2007), 6 vom: 19. Juni, Seite 766-773</subfield><subfield code="w">(DE-627)NLEJ248235222</subfield><subfield code="w">(DE-600)1492732-9</subfield><subfield code="x">1437-4331</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:45</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:6</subfield><subfield code="g">day:19</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:766-773</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/CCLM.2007.164</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DGR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">45</subfield><subfield code="j">2007</subfield><subfield code="e">6</subfield><subfield code="b">19</subfield><subfield code="c">06</subfield><subfield code="h">766-773</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.4008236 |